Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Levorotatory alkaloids of belladonna |
Is a |
True |
Belladonna (substance) |
Inferred relationship |
Some |
|
Belladonna alkaloids adverse reaction |
Causative agent |
False |
Belladonna (substance) |
Inferred relationship |
Some |
1 |
Allergy to belladonna alkaloid |
Causative agent |
False |
Belladonna (substance) |
Inferred relationship |
Some |
|
Belladonna alkaloid (substance) |
Is a |
True |
Belladonna (substance) |
Inferred relationship |
Some |
|
Belladonna alkaloid 16.2 mg and opium 30 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
|
Belladonna alkaloid 16.2 mg and opium 60 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
|
opium + belladonna |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
|
belladonnin |
Is a |
False |
Belladonna (substance) |
Inferred relationship |
Some |
|
aluminiumhydroxid + belladonna som mikstur |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
|
belladonna 0,05 mg/5 ml pædiatrisk væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
|
magnesiumtrisilicat + belladonna 0,15 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
|
belladonna-præparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
|
Belladonna alkaloid 15 mg and secbutabarbital sodium 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
|
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
|
belladonna-alkaloider 0,2 mg + ergotamintartrat 0,6 mg + phenobarbital 40 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
|
aluminiumhydroxid + belladonna |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
|
belladonna + butabarbitalnatrium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
|
belladonna-alkaloider + ergotamintartrat + phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
|
magnesiumtrisilikat + belladonna |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
|
Product containing belladonna in rectal dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
|
Product containing belladonna in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
|
Belladonna alkaloid 15 mg and secbutabarbital sodium 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
1 |
Belladonna alkaloid 15 mg and secbutabarbital sodium 15 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Belladonna (substance) |
Inferred relationship |
Some |
2 |